NM_001184900.3:c.306C>G

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACMG Germline Pathogenicity v2019). PM2BP4_Moderate

The NM_001184900.3(CARD8):c.306C>G (p.Phe102Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.F102I: Benign (ClinVar VariationId 1166485, 2 stars); p.S11= (synonymous): Uncertain_significance (ClinVar VariationId 1423300, 1 star)

Frequency

Genomes: not found (cov: 32)

Consequence

CARD8
NM_001184900.3 missense

Scores

3
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.357

Publications

0 publications found
Variant links:
Genes affected
CARD8 (HGNC:17057): (caspase recruitment domain family member 8) The protein encoded by this gene belongs to the caspase recruitment domain (CARD)-containing family of proteins, which are involved in pathways leading to activation of caspases or nuclear factor kappa-B (NFKB). This protein may be a component of the inflammasome, a protein complex that plays a role in the activation of proinflammatory caspases. It is thought that this protein acts as an adaptor molecule that negatively regulates NFKB activation, CASP1-dependent IL1B secretion, and apoptosis. Polymorphisms in this gene may be associated with a susceptibility to rheumatoid arthritis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2010]
CARD8 Gene-Disease associations (from GenCC):
  • inflammatory bowel disease 30
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001184900.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (threshold 0.0001) — PM2 moderate.
BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001184900.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CARD8 NM_001184900.3
MANE Select
HGVSc / HGVSpc.306C>Gp.Phe102Leu
Exon rankExon 6 of 14
missense
Prot: NP_001171829.1UniProt: Q9Y2G2-5
CARD8 NM_001351786.2
HGVSc / HGVSpc.-183C>G
Exon rankExon 4 of 13
5_prime_UTR_premature_start_codon_gain
Prot: NP_001338715.1
CARD8 NM_001351782.2
HGVSc / HGVSpc.306C>Gp.Phe102Leu
Exon rankExon 7 of 15
missense
Prot: NP_001338711.1UniProt: Q9Y2G2-5

Ensembl Transcripts

CARD8 ENST00000651546.1
MANE Select
HGVSc / HGVSpc.306C>Gp.Phe102Leu
Exon rankExon 6 of 14
missense
Prot: ENSP00000499211.1UniProt: Q9Y2G2-5
CARD8 ENST00000391898.7
TSL:1
HGVSc / HGVSpc.306C>Gp.Phe102Leu
Exon rankExon 3 of 11
missense
Prot: ENSP00000375767.3UniProt: Q9Y2G2-5
CARD8 ENST00000520153.5
TSL:1
HGVSc / HGVSpc.156C>Gp.Phe52Leu
Exon rankExon 4 of 12
missense
Prot: ENSP00000428736.1UniProt: Q9Y2G2-4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:30
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic22
AlphaMissense
Pathogenic0.94
BayesDel_addAF
Benign-0.27T
BayesDel_noAF
Benign-0.63
CADD
Benign7.2
DANN
Benign0.49
Eigen
Benign-1.1
Eigen_PC
Benign-1.3
FATHMM_MKL
Benign0.018N
FuncVEP CTI
Benign0.0035
GPN-Star LLR
N/A0.23
GPN-Star score
N/A-0.23
LIST_S2
Benign0.47T
M_CAP
Benign0.0012T
MetaRNN
Benign0.088T
MetaSVM
Benign-0.99T
Mutation Taster
N/A97/3polymorphism
PhyloP100
Benign0.36
popEVE
Benign-3.2
PrimateAI
Benign0.40T
PROVEAN
Benign0.40N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Benign0.011
Sift
Pathogenic0.0D
Sift4G
Pathogenic0.0D
Showing 26 of 26 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.